The transit of dosage forms through the colon.
Colonic transit is a subject of great relevance when considering in vivo/in vitro relationships for oral controlled release dosage forms. Our knowledge of colonic motility has first come from the clinic, where measurement of the whole gut transit of different excreted markers was used as a method of discriminating pathologies. X-ray contrast, although widely available, was used sparing due to the accumulating dosimetry associated with each exposure. Although such methods were used for swallowing studies, gamma scintigraphy allowed physicians to measure colon function with a more moderate radiation burden. The ability to label meal and dosage form separately and to measure dispersion with more certainty, prompted the use in pharmaceutical sciences; finally, the relationship between blood concentrations and transit of different sized dosage began to be understood. This mini-review considers the development of colon transit measurements and how different designs of clinical assessment assist in elucidating size and shape influence on colon transit in man.
Wilson
Clive G
CG
Strathclyde Institute of Pharmacy & Biomedical Sciences, Glasgow G4 0NR, Scotland, UK. c.g.wilson@strath.ac.uk
D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D003106:Colon / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000502:physiology*; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D004326:Drinking; D004334:Drug Administration Schedule; D004435:Eating; D005247:Feeding Behavior; D005772:Gastrointestinal Transit; D006801:Humans; D010316:Particle Size; D011877:Radionuclide Imaging; D013997:Time Factors
D003692:Delayed-Action Preparations; D004304:Dosage Forms